A phase I study of biweekly capecitabine and the histone deacetylase inhibitors (HDACi) vorinostat in advanced breast cancer (BC).
M. M. Abu-Khalaf
Research Funding - Roche/Genentech
T. Kim
No relevant relationships to disclose
G. G. Chung
No relevant relationships to disclose
M. DiGiovanna
No relevant relationships to disclose
S. Radke
No relevant relationships to disclose
D. Cornfeld
No relevant relationships to disclose
L. Harris
No relevant relationships to disclose